EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit® RS, Ethyl Cellulose and Polyethylene Oxide

Vanessa Domsta, Tessa Boralewski, Martin Ulbricht, Philipp Schick, Julius Krause, Anne Seidlitz

International Journal of Pharmaceutics: X · 2024-12 · 8 · 100263

DOI: 10.1016/j.ijpx.2024.100263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutics: X, 2024-12. Verfasst von Vanessa Domsta und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Greifswald, Institute of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Felix-Hausdorff-Str. 3, 17489 Greifswald, Germany. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Federal Ministry of Education and Research Berlin Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hot-melt extrusion (HME) potentially coupled with 3D printing is a promising technique for the manufacturing of dosage forms such as drug-eluting implants which might even be individually adapted to patient-specific anatomy. However, these manufacturing methods involve the risk of thermal degradation of incorporated drugs during processing. In this work, the stability of the anti-inflammatory drug dexamethasone (DEX) was studied during HME using the polymers Eudragit® RS, ethyl cellulose and polyethylene oxide. The extrusion process was performed at different temperatures. Furthermore, the influence of accelerated screw speed, the addition of the plasticizers triethyl citrate and polyethylene glycol 6000 or the addition of the antioxidants butylated hydroxytoluene and tocopherol in two concentrations were studied. The DEX recovery was analyzed by a high performance liquid chromatography method suitable for the detection of thermal degradation products. The strongest impact on the drug stability was found for the processing temperature, which was found to reduce the DEX recovery to

Schlagwörter

Stichwörter der Autor:innen

DegradationDexamethasoneEthyl celluloseEudragit® RSHot-melt extrusionPolyethylene oxide

Autor:innen und Institutionen

  • University of Greifswald, Institute of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Felix-Hausdorff-Str. 3, 17489 Greifswald, Germany.
  • Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutics and Biopharmaceutics, Universitätsstr. 1, 40225 Düsseldorf, Germany.

Förderung

  • Bundesministerium für Bildung und Forschung
  • Federal Ministry of Education and Research Berlin Office

Zitieren

APA

Domsta, V., Boralewski, T., Ulbricht, M., Schick, P., Krause, J., & Seidlitz, A. (2024). Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit® RS, Ethyl Cellulose and Polyethylene Oxide. International Journal of Pharmaceutics: X, 8, 100263. https://doi.org/10.1016/j.ijpx.2024.100263

Vancouver

Domsta V, Boralewski T, Ulbricht M, Schick P, Krause J, Seidlitz A. Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit® RS, Ethyl Cellulose and Polyethylene Oxide. International Journal of Pharmaceutics: X. 2024;8:100263. doi:10.1016/j.ijpx.2024.100263

BibTeX
@article{Domsta2024,
  author = {Domsta, Vanessa and Boralewski, Tessa and Ulbricht, Martin and Schick, Philipp and Krause, Julius and Seidlitz, Anne},
  title = {Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit® RS, Ethyl Cellulose and Polyethylene Oxide},
  journal = {International Journal of Pharmaceutics: X},
  year = {2024},
  volume = {8},
  pages = {100263},
  doi = {10.1016/j.ijpx.2024.100263}
}
Kostenlos starten →